Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term PROSTATE-CANCER. Found 15 abstracts

Manne S, Kashy D, Albrecht T, Wong YN, Flamm AL, Benson AB, Miller SM, Fleisher L, Buzaglo J, Roach N, Katz M, Ross E, Collins M, Poole D, Raivitch S, Miller DM, Kinzy TG, Liu T, Meropol NJ. Knowledge, Attitudes, and Self-efficacy as Predictors of Preparedness for Oncology Clinical Trials: A Mediational Model. Medical Decision Making. 2014 May;34(4):454-63.   PMCID: PMC3991731
Stathakis S, Roland T, Papanikolaou N, Li JS, Ma C. A Prediction Study on Radiation-induced Second Malignancies for IMRT Treatment Delivery. Technology in Cancer Research & Treatment. 2009 Apr;8(2):141-7.
Williams SJ, Cvetkovic D, Hamilton TC. Vitamin A metabolism is impaired in human ovarian cancer. Gynecologic Oncology. 2009 Mar;112(3):637-45.   PMCID: PMC 2737361
Gururajan M, Simmons A, Dasu T, Spear BT, Calulot C, Robertson DA, Wiest DL, Monroe JG, Bondada S. Early growth response genes regulate B cell development, proliferation, and immune response. Journal of Immunology. 2008 Oct;181(7):4590-602.
Siddiqui F, Pajak TF, Watkins-Bruner D, Konski AA, Coyne JC, Gwede CK, Garden AS, Spencer SA, Jones C, Movsas B. Pretreatment quality of life predicts for locoregional control in head and neck cancer patients: A radiation therapy oncology group analysis. International Journal of Radiation Oncology Biology Physics. 2008 Feb;70(2):353-60.
Bell DW, Kim SH, Godwin AK, Schiripo TA, Harris PL, Haserlat SM, Wahrer DC, Haiman CA, Daly MB, Niendorf KB, Smith MR, Sgroi DC, Garber JE, Olopade OI, Le Marchand L, Henderson BE, Altshuler D, Haber DA, Freedman ML. Genetic and functional analysis of CHEK2 (CHK2) variants in multiethnic cohorts. International journal of cancer. 2007 Dec;121(12):2661-7.
de Caceres, Cairns P. Methylated DNA sequences for early cancer detection, molecular classification and chemotherapy response prediction. Clinical & Translational Oncology. 2007 Jul;9(7):429-37.
Hensley H, Quinn BA, Wolf RL, Litwin SL, Mobuchi S, Williams SJ, Williams C, Hamilton TC, Connolly DC. Magnetic resonance imaging for detection and determination of tumor volume in a genetically engineered mouse model of ovarian cancer. Cancer Biology & Therapy. 2007 Nov;6(11):1717-25.
Lee H, Kim D, Dan HC, Wu EL, Gritsko TM, Cao CH, Nicosia SV, Golemis EA, Liu WG, Coppola D, Brem SS, Testa JR, Cheng JQ. Identification and characterization of putative tumor suppressor NGB, a GTP-binding protein that interacts with the neurofibromatosis 2 protein. Molecular and Cellular Biology. 2007 Mar;27(6):2103-19.
Lutz ST, Chow EL, Hartsell WF, Konski AA. A review of hypofractionated palliative radiotherapy. Cancer. 2007 Apr;109(8):1462-70.
Murphy MJ, Balter J, Balter S, BenComo JA, Das IJ, Jiang SB, Ma CM, Olivera GH, Rodebaugh RF, Ruchala KJ, Shirato H, Yin FF. The management of imaging dose during image-guided radiotherapy: Report of the AAPM Task Group 75. Medical Physics. 2007 Oct;34(10):4041-63.
Roach M, De Silvio M, Rebbick T, Grignon D, Rotman M, Wolkov H, Fisher B, Hanks G, Shipley WU, Pollack A, Sandler H, Watkins-Bruner D. Racial differences in cyp3a4 genotype and survival among men treated on radiation therapy oncology group (rtog) 9202: A phase III randomized trial. International Journal of Radiation Oncology Biology Physics. 2007 Sep;69(1):79-87.
Cohen SJ, Alpaugh RK, Gross S, O'Hara SM, Smirnov DA, Ferstappen L, Allard WJ, Bilbee M, Cheng JD, Hoffman JP, Lewis NL, Pellegrino A, Rogatko A, Sigurdson E, Wang H, Watson JC, Weiner LM, Meropol NJ. Isolation and characterization of circulating tumor cells in patients with metastatic colorectal cancer. Clinical Colorectal Cancer. 2006 Jul;6(2):125-32.
Konski A, Watkins-Bruner D. The RTOG Outcomes Model: economic end points and measures. Expert Opinion on Pharmacotherapy. 2004 Mar;5(3):513-9.
Lareef MH, Tahin Q, Song J, Russo IH, Mihaila D, Slater CM, Balsara B, Testa JR, Broccoli D, Grobelny JV, Mor G, Cuthbert A, Russo J. Chromosome 17p13.2 transfer reverts transformation phenotypes and Fas-mediated apoptosis in breast epithelial cells. Molecular Carcinogenesis. 2004 Apr;39(4):234-46.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term PROSTATE-CANCER

PROSTATE-CANCER RADIOTHERAPY BREAST-CANCER CELL LUNG-CANCER radiotherapy KeyWords Plus: RISK TUMOR-SUPPRESSOR EXPRESSION CHEMOTHERAPY RADIATION-THERAPY MRI THERAPY factor Health Care Sciences & Services Monte Carlo CELL-ADHESION COSTS SPONTANEOUS EGR TRANSCRIPTION FACTORS GENE-EXPRESSION PLUS IRINOTECAN CARCINOMA-CELLS IMRT ESCALATION FLUOROURACIL BLOOD CANCER CELLS health-related quality of life ASSOCIATION WOMEN Fas ADVANCED PELVIC PROTEIN-KINASE IMMEDIATE-EARLY GENE GROWTH SUPPRESSION T-CELLS GENE NGFI-A TELOMERASE ACTIVITY FUNCTIONAL ASSESSMENT DOSE-RESPONSE chromosome 17p132 clinical trials HETEROZYGOSITY prognostic hypofractionation GENETIC VARIANT TRANSGENIC MICE ALLELE LOSS HODGKINS-DISEASE ONCOLOGY GROUP RTOG locoregional control SINGLE FRACTION Ovarian NF2 LEUCOVORIN BLADDER-CANCER IN-VITRO CLINICAL PRESENTATION IN-VIVO HEREDITARY BREAST-CANCER PATIENT SETUP FHA DOMAIN PROMOTER HYPERMETHYLATION Ottawa Decision Support Framework CHEMICAL-CARCINOGENS chemotherapy response PAINFUL BONE METASTASES apoptosis MALIGNANCIES MUTATION ANALYSIS CONE-BEAM-CT DNA-DAMAGE CHECKPOINT cytotoxic chemotherapy cancer Vitamin A INVASIVE BLADDER-CANCER LEUKEMIA RISK KLF6 BONE-MARROW FAMILY-HISTORY Second malignancy CLINICAL-TRIALS MALIGNANT GLIOMA MULTIPLE FRACTIONS race CHEK2-ASTERISK-1100DELC POLYSACCHARIDE ANTIGENS ERM PROTEINS preclinical GSTP1 HYPERMETHYLATION MICROSATELLITE INSTABILITY TYPE-2 GENE-PRODUCT RANDOMIZED CONTROLLED-TRIAL 8 GY early cancer diagnosis RECEPTOR CPG ISLAND PROGRESSION PROGNOSTIC-FACTORS ovarian cancer targeted therapeutics symptom control Cellular retinol binding protein 1 TRANSFORMATION OOPHORECTOMY SPECIMENS MERLIN PHOSPHORYLATION EORTC QLQ-C30 Cancer PARTICIPATION ENROLLMENT susceptibility cHEK2-breast-cancer-mutation RETINOL-BINDING-PROTEIN genetic polymorphisms DISTRESS transformation phenotypes transgenic mouse model PROTOCOL HEALTH BELIEF MODEL model COMPUTED-TOMOGRAPHY DATA BRCA1 MUTATIONS PROPHYLACTIC SURVIVAL HAPLOTYPES CANCER-PATIENTS VALIDITY SURFACE EPITHELIAL-CELLS human breast epithelial cells Medical Informatics GROWTH MONOTHERAPY MRI micro-imaging head and neck cancer 3D-CRT POSTMENOPAUSAL TUMOR-SUPPRESSOR GENES IONIZING-RADIATION prostate cancer methylation biomarkers SHORT ARM FLAT-PANEL IMAGER TUMOR LONG ADJUSTED SURVIVAL ANALYSIS Conventional radiotherapy METHYLTRANSFERASES MEGAVOLTAGE PHOTON BEAMS surrogate tumor markers LINEAR-ACCELERATOR
Last updated on Monday, November 04, 2019